Diabetes doesn’t hinder PCI success in treating CTO

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Patients with diabetes who have chronic total occlusion (CTO) are just as likely as those without diabetes to benefit from percutaneous coronary intervention (PCI).

Why this matters

  • CTOs are more common in patients with diabetes, yet they are less likely to be offered PCI.
  • ...